Trials / Completed
CompletedNCT00000318
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 202 (actual)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine | 1. Experimental Maintenance treatment with daily medication 2. Experimental Maintenance treatment with thrice-weekly medication |
Timeline
- Start date
- 1994-12-01
- Primary completion
- 2004-03-01
- Completion
- 2007-08-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000318. Inclusion in this directory is not an endorsement.